Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TLRY
TLRY logo

TLRY Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
5.115
Open
5.115
VWAP
5.12
Vol
91.30K
Mkt Cap
618.35M
Low
5.115
Amount
466.98K
EV/EBITDA(TTM)
34.56
Total Shares
119.60M
EV
661.09M
EV/OCF(TTM)
--
P/S(TTM)
0.64
Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. Its adult-use portfolio offers a range of products, from flowers to beverages. Its beverage-alcohol portfolio includes a selection of craft beer, spirits, and beverages.
Show More

Events Timeline

(ET)
2026-04-23
13:10:00
Roth Capital: Cannabis Products Rescheduled to Schedule 3
select
2026-04-23
10:30:00
Trump Orders Medical Marijuana Products to Schedule III
select
2026-04-23
10:00:00
Trump Signs Order to Reschedule Medical Marijuana to Schedule III
select
link
2026-04-22 (ET)
2026-04-22
12:00:00
Tilray Trading Resumes
select
2026-04-22
12:00:00
Trump Administration Expected to Reclassify Cannabis on Wednesday
select
link
2026-04-22
11:50:00
Tilray Trading Halted Due to High Volatility
select

News

Newsfilter
8.5
10:43 AMNewsfilter
PinnedTilray Launches ARX Medical Cannabis Brand in Germany
  • Brand Launch: Tilray Medical Germany officially launched ARX on June 10, 2026, marking a significant milestone for the company in the German market, which is expected to enhance demand for high-quality products among patients and healthcare professionals.
  • Development Background: The introduction of the ARX brand follows over two years of development at the Aphria RX facility in Neumünster, combining premium genetics from Broken Coast with cultivation expertise from Canada to ensure product consistency and high standards.
  • Production Standards: ARX is produced under strict EU-GMP standards, utilizing climate-controlled grow rooms with real-time monitoring and adjustments to maintain quality for each cultivar, reflecting Tilray's commitment to patient needs.
  • Market Strategy: By partnering with CC Pharma and 14U Pharma for national distribution, Tilray not only enhances its supply capabilities in the German market but also strengthens its leadership position in the European medical cannabis industry by providing locally produced, high-quality products.
stocktwits
8.5
02:10 AMstocktwits
PinnedTilray Issues Shares for Lyphe Group Acquisition and Debt Swap
  • Acquisition of Lyphe Group: Tilray issued 398,666 shares on April 15 as partial payment for its acquisition of Lyphe Group, a platform that has treated over 16,000 patients, which is expected to boost the company's earnings next year.
  • Successful Debt Swap: The company issued 1.21 million shares on June 3 in a private debt-for-equity exchange, retiring $6 million of its 5.2% Convertible Senior Notes without requiring cash, thereby improving its financial position.
  • Positive Market Reaction: Tilray's stock jumped 3% on Tuesday, marking its best performance in over two weeks, reflecting investor optimism regarding the company's shift towards beverage operations.
  • Favorable Policy Impact: With improving cannabis policies in the U.S., sentiment around Tilray has turned extremely bullish, especially in light of an upcoming hearing that could lead to broader rescheduling of marijuana products.
stocktwits
8.5
13:10 PMstocktwits
Tilray Launches ARX Premium Medical Cannabis Brand in Germany
  • Brand Launch: Tilray is set to introduce the ARX brand in Germany, marking its first premium medical cannabis brand aimed at meeting the growing demand for medicinal flower in the country, representing a significant milestone for the company in the German market.
  • Local Cultivation: The medicinal flower for the ARX brand will be cultivated at the Aphria RX facility in Neumünster, utilizing strains sourced from Canada, ensuring that product quality meets the needs of patients and healthcare professionals.
  • Market Strategy: The decision to launch a premium medical cannabis offering is strategic, aimed at increasing profits by tapping into the high-margin product category in Europe’s largest cannabis market, leveraging Tilray's existing expertise in the field.
  • Market Sentiment: Retail sentiment regarding TLRY stock has remained 'extremely bullish' over the past 24 hours, with the stock gaining over 26% in the past 12 months, outperforming the benchmark S&P index, although it still lags behind popular cannabis ETF AdvisorShares Pure US Cannabis ETF.
Newsfilter
8.5
11:40 AMNewsfilter
BrewDog Partners with Tilray to Launch American Craft Beers in the UK
  • Market Expansion Strategy: BrewDog's collaboration with Tilray to launch 24 American craft beers marks Tilray's debut in the UK market, expected to rapidly enhance brand visibility through BrewDog's channels and further expand its market share in Europe.
  • Consumer Appeal: Initial research indicates that over 50% of beer drinkers find the new brands either very appealing or somewhat appealing, particularly among consumers aged 18-34, highlighting significant demand potential for American craft beers.
  • Product Diversity: The launch features a variety of styles, including Sweetwater's fruity IPAs and Montauk's Summer Ale, catering to diverse consumer taste preferences and likely strengthening BrewDog's central role in craft beer culture.
  • Promotional Activities: BrewDog will offer U.S. beer flight packages at £12.95 in its bars, supported by high-energy promotions tied to summer sports events, which is expected to attract more consumers to experience American craft beers and drive sales growth.
stocktwits
4.0
03:10 AMstocktwits
U.S. Launches Self-Defense Strikes Against Iran Amid Rising Tensions
  • Market Reaction: On Tuesday, the S&P 500 fell by 0.26% and the Nasdaq dropped by 1.12%, indicating market sensitivity to the pullback in chip stocks and extending last week's downturn, reflecting investor concerns over long-term returns.
  • Military Action: The U.S. Central Command announced that self-defense strikes directed by President Trump against Iran were in response to the downing of an American helicopter near the Strait of Hormuz, a move that could escalate tensions and impact future peace negotiations.
  • Oil Price Fluctuations: Oil prices edged higher in overnight trading due to escalating tensions in the Middle East, with Brent crude futures rising about 0.45% to $91.86 per barrel and WTI crude futures increasing by 0.36% to $88.52 per barrel, highlighting market sensitivity to geopolitical risks.
  • Investor Sentiment: As American investors rotate out of AI and chip stocks again, market sentiment appears cautious, with analysts noting that while signs of correction are emerging, the fundamental outlook has not significantly deteriorated, prompting attention to the upcoming Consumer Price Index (CPI) data.
stocktwits
8.5
06-09stocktwits
Trulieve to Uplist on NYSE Amid Regulatory Changes
  • Listing Milestone: Trulieve is set to begin trading on the NYSE under the symbol TRLV on Wednesday, with CEO Kim Rivers calling it a 'historic milestone' that signifies the company's successful restructuring in the medical cannabis sector, which is expected to attract more investor attention.
  • Optimistic Industry Outlook: AdvisorShares noted that the rescheduling of medical marijuana could enhance earnings, cash flow, and capital access across the industry, particularly ahead of the upcoming DEA hearing, which has heightened market sentiment.
  • Strong ETF Performance: As of May 31, the AdvisorShares Pure US Cannabis ETF (MSOS) delivered a remarkable 103.7% one-year net asset value return, significantly outperforming the North American Marijuana Index's 36.9% and the S&P 500's 29.8%, reflecting strong investor interest in cannabis stocks.
  • Increased Financing Opportunities: With the implementation of tax deductions for medical marijuana products, Cresco Labs secured a $50 million revolving credit facility, with the CEO stating that this provides a powerful non-dilutive financing tool to support future uplisting plans.
Wall Street analysts forecast TLRY stock price to rise
4 Analyst Rating
Wall Street analysts forecast TLRY stock price to rise
1 Buy
3 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
8.50
Averages
9.57
High
10.00
Current: 0.000
sliders
Low
8.50
Averages
9.57
High
10.00
Canaccord
Hold
downgrade
$13
AI Analysis
2026-04-02
Reason
Canaccord
Price Target
$13
AI Analysis
2026-04-02
downgrade
Hold
Reason
Canaccord lowered the firm's price target on Tilray to C$9.50 from C$13 and keeps a Hold rating on the shares.
Roth Capital
Bill Kirk
Neutral
to
Buy
upgrade
$10
2026-04-01
Reason
Roth Capital
Bill Kirk
Price Target
$10
2026-04-01
upgrade
Neutral
to
Buy
Reason
Roth Capital analyst Bill Kirk upgraded Tilray to Buy from Neutral with an unchanged $10 price target. The firm is citing the company's core Canadian business holding steady, inflection in Tilray's international operations and improving beverage category, the analyst tells investors in a research note. Tilray shares are back at July 2025 levels, but the fundamental outlook has improved and the potential for regulatory change is greater, the firm added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for TLRY
Unlock Now

Valuation Metrics

The current forward P/E ratio for Tilray Brands Inc (TLRY.O) is 1000.00, compared to its 5-year average forward P/E of 79.47. For a more detailed relative valuation and DCF analysis to assess Tilray Brands Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
79.47
Current PE
1000.00
Overvalued PE
402.62
Undervalued PE
-243.68

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
34.15
Current EV/EBITDA
-1.49
Overvalued EV/EBITDA
70.55
Undervalued EV/EBITDA
-2.25

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
2.81
Current PS
0.54
Overvalued PS
5.46
Undervalued PS
0.17

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

how is cannibis securities doing today
Intellectia · 8 candidates
Market Cap: >= 100.00MPrice: >= $1.00Themes: The Cannabis IndustryMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
CGC logo
CGC
Canopy Growth Corp
511.04M
TLRY logo
TLRY
Tilray Brands Inc
803.02M
SNDL logo
SNDL
SNDL Inc
391.39M
VFF logo
VFF
Village Farms International Inc
328.97M
ACB logo
ACB
Aurora Cannabis Inc
201.89M
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.49B
best day trade stock
Intellectia · 9 candidates
Price: $5.00 - $100.00Volume: >= 3,000,000Price Change Pct: >= $3.00Relative Vol: >= 2Beta: HighRisk
Ticker
Name
Market Cap$
top bottom
KODK logo
KODK
Eastman Kodak Co
1.10B
ORIC logo
ORIC
Oric Pharmaceuticals Inc
995.75M
LUNR logo
LUNR
Intuitive Machines Inc
5.20B
RLAY logo
RLAY
Relay Therapeutics Inc
2.24B
GSAT logo
GSAT
Globalstar Inc
10.00B
AEHR logo
AEHR
Aehr Test Systems
1.36B
what penny stocks to buy pre market 4/1/26
Intellectia · 14 candidates
Market Cap: 100.00M - 2.00BRegion: USVolume: >= 200,000Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEPre Market Price Change: $3.00 - $20.00
Ticker
Name
Market Cap$
top bottom
TLRY logo
TLRY
Tilray Brands Inc
753.80M
OMER logo
OMER
Omeros Corp
748.71M
VOR logo
VOR
Vor Biopharma Inc
871.44M
VALN logo
VALN
Valneva SE
542.98M
SLNO logo
SLNO
Soleno Therapeutics Inc
1.73B
SGMO logo
SGMO
Sangamo Therapeutics Inc
102.28M
Give me the top 5 cannabis companies
Intellectia · 4 candidates
Market Cap: >= 500.00MRevenue Ttm: >= 100.00MRegion: USThemes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.52B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.43B
CRON logo
CRON
Cronos Group Inc
947.63M
TLRY logo
TLRY
Tilray Brands Inc
736.32M
Should I Buy cannabis stocks?
Intellectia · 9 candidates
Market Cap: >= 50.00MThemes: The Cannabis IndustryList Exchange: XNYS, XNASMonthly Average Dollar Volume: >= 100,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
what cannabis stocks would you buy?
Intellectia · 4 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryQuarter Revenue Yoy Growth: >= 0.0%Monthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
SNDL logo
SNDL
SNDL Inc
386.25M
ACB logo
ACB
Aurora Cannabis Inc
204.15M
cannabis
Intellectia · 8 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryIs Optionable: TrueMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
marijuana stocks
Intellectia · 8 candidates
Market Cap: >= 200.00MRegion: US, CanadaPrice: >= $1.00Themes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
CGC logo
CGC
Canopy Growth Corp
460.70M
SNDL logo
SNDL
SNDL Inc
406.85M
which. cannabisindustry should I invest in
Intellectia · 2 candidates
Market Cap: >= 500.00MThemes: The Cannabis IndustryWeekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
Cannibus stocks
Intellectia · 4 candidates
Market Cap: >= 500.00MThemes: The Cannabis IndustryBeta: ModerateRisk, HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M

Whales Holding TLRY

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Tilray Brands Inc (TLRY) stock price today?

The current price of TLRY is 5.115 USD — it has decreased -1.06

What is Tilray Brands Inc (TLRY)'s business?

Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. Its adult-use portfolio offers a range of products, from flowers to beverages. Its beverage-alcohol portfolio includes a selection of craft beer, spirits, and beverages.

What is the price predicton of TLRY Stock?

Wall Street analysts forecast TLRY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TLRY is9.57 USD with a low forecast of 8.50 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Tilray Brands Inc (TLRY)'s revenue for the last quarter?

Tilray Brands Inc revenue for the last quarter amounts to 206.73M USD, increased 11.28

What is Tilray Brands Inc (TLRY)'s earnings per share (EPS) for the last quarter?

Tilray Brands Inc. EPS for the last quarter amounts to -0.24 USD, decreased -97.24

How many employees does Tilray Brands Inc (TLRY). have?

Tilray Brands Inc (TLRY) has 2842 emplpoyees as of June 10 2026.

What is Tilray Brands Inc (TLRY) market cap?

Today TLRY has the market capitalization of 618.35M USD.